SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022
Share
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 209.09 million compared to TWD 216.34 million a year ago. Net income was TWD 68.82 million compared to TWD 22.25 million a year ago. Basic earnings per share from continuing operations was TWD 1.72 compared to TWD 0.74 a year ago. Diluted earnings per share from continuing operations was TWD 1.72 compared to TWD 0.74 a year ago.
For the six months, sales was TWD 368.61 million compared to TWD 451.92 million a year ago. Net income was TWD 103.06 million compared to TWD 74.22 million a year ago. Basic earnings per share from continuing operations was TWD 2.57 compared to TWD 2.47 a year ago. Diluted earnings per share from continuing operations was TWD 2.57 compared to TWD 2.47 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
